Better prospects for diagnostic test reimbursement in Germany
This article was originally published in Clinica
Executive Summary
Germany's diagnostics industry association (VDGH) has welcomed the recently-expressed view of the federal government that the inclusion of medical procedures in the reimbursement catalogue of the statutory sickness funds (GKV) should be simpler and more transparent. "Should this sentiment become a hard-and-fast decision, there would be hope that new lab tests will also, finally, be made available to those with sickness insurance," said the Frankfurt-based association's chairman, Volker Oeding.